Sotera flexes $1.77 billion term loan B to Libor plus 275 bps

By Sara Rosenberg

New York, Jan. 15 – Sotera Health Co. reduced pricing on its $1.768 billion term loan B due December 2026 to Libor plus 275 basis points from talk in the range of Libor plus 300 bps to 325 bps, according to a market source.

Additionally, the issue price on the term loan firmed at par, the tight end of the 99.5 to par talk, the source said.

The term loan still has a 0.5% Libor floor and 101 soft call protection for six months.

J.P. Morgan Securities LLC is the lead on the deal.

Proceeds will be used to reprice an existing term loan B down from Libor plus 450 bps with a 1% Libor floor.

Sotera is a Broadview Heights, Ohio-based provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the health care industry.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.